Cellular, molecular and biological insight into chemopreventive and therapeutic potential of 3,3'-diindolylmethane (DIM)

Nutraceuticals and Cancer

Volumn 9789400726307, Issue , 2012, Pages 111-133

  Banerjee, Sanjeev ^a   Parasramka, Mansi A ^a   Sarkar, Fazlul H ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

3,3' Diindolylmethane; Brassica genus; Prevention; Therapy

Indexed keywords

EID: 84865422276     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-2630-7_6     Document Type: Chapter

References (94)

1. Abdelrahim M, Newman K, Vanderlaag K et al (2006) 3, 3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stressdependent upregulation of DR5. Carcinogenesis 27:717-728
2. Ahmad A, Kong D, Sarkar SH et al (2009a) Inactivation of uPA and its receptor uPAR by 3, 3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration. J Cell Biochem 107:516-527
3. Ahmad A, Kong D, Wang Z et al (2009b) Down-regulation of uPA and uPAR by 3, 3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells. J Cell Biochem 108:916-925
4. Ahmad A, Ali S, Wang Z et al (2011) 3, 3'-diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through down-regulation of FoxM1. Int J Cancer 129:1781-1791
5. Ali S, Banerjee S, Ahmad A et al (2008) Apoptosis-inducing effect of erlotinib is potentiated by 3, 3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer. Mol Cancer Ther 7:1708-1719
6. Ali S, Varghese L, Pereira L et al (2009) Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents. Cancer Lett 278:201-209
7. Ali S, Banerjee S, Schaffert JM et al (2010) Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer. J Cell Biochem 110:171-181
8. Auborn KJ (2002) Therapy for recurrent respiratory papillomatosis. Antivir Ther 7:1-9
9. Azmi AS, Ahmad A, Banerjee S et al (2008) Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3, 3' diindolylmethane (DIM). Pharm Res 25:2117-2124
10. Banerjee S, Wang Z, Kong D et al (2009) 3, 3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer. Cancer Res 69:5592-5600
11. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215-233
12. Bhatnagar N, Li X, Chen Y et al (2009) 3, 3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin. Cancer Prev Res (Phila Pa) 2:581-589
13. Bhuiyan MM, Li Y, Banerjee S et al (2006) Down-regulation of androgen receptor by 3, 3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Res 66:10064-10072
14. Bonnesen C, Eggleston IM, Hayes JD (2001) Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 61:6120-6130
15. Cano E, Mahadevan LC (1995) Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20:117-122
16. Casalini P, Iorio MV (2009) MicroRNAs and future therapeutic applications in cancer. J BUON 14 Suppl 1:S17-S22
17. Chang X, Tou JC, Hong C et al (2005) 3, 3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26:771-778
18. Chang X, Firestone GL, Bjeldanes LF (2006) Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3, 3'-diindolylmethane. Carcinogenesis 27:541-550
19. Chen DZ, Qi M, Auborn KJ et al (2001) Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. J Nutr 131:3294-302
20. Chen Y, Xu J, Jhala N et al (2006) Fas-mediated apoptosis in cholangiocarcinoma cells is enhanced by 3, 3'-diindolylmethane through inhibition of AKT signaling and FLICE-like inhibitory protein. Am J Pathol 169:1833-1842
21. Cheng JS, Shu SS, Kuo CC et al (2011) Effect of diindolylmethane on Ca (2+) movement and viability in HA59T human hepatoma cells. Arch Toxicol 85:1257-1266
22. Chinnakannu K, Chen D, Li Y et al (2009) Cell cycle-dependent effects of 3, 3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells. J Cell Physiol 219:94-99
23. Cho HJ, Park SY, Kim EJ et al (2011) 3, 3'-Diindolylmethane inhibits prostate cancer development in the transgenic adenocarcinoma mouse prostate model. Mol Carcinog 50:100-112
24. Choi HJ, Lim D Y, Park JH (2009) Induction of G1 and G2/M cell cycle arrests by the dietary compound 3, 3'-diindolylmethane in HT-29 human colon cancer cells. BMC Gastroenterol 9:39
25. Contractor R, Samudio IJ, Estrov Z et al (2005) A novel ring-substituted diindolylmethane, 1, 1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia. Cancer Res 65:2890-2898
26. Crowell JA, Page JG, Levine BS et al (2006) Indole-3-carbinol, but not its major digestive product 3, 3'-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450. Toxicol Appl Pharmacol 211:115-123
27. Degner SC, Papoutsis AJ, Selmin O et al (2009) Targeting of aryl hydrocarbon receptormediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3, 3'-diindolylmethane in breast cancer cells. J Nutr 139:26-32
28. Del PG, Gudipudi DK, Montemarano N et al (2010) Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecol Oncol 116:464-467
29. Dong L, Xia S, Gao F et al (2010) 3, 3'-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis. Biochem Pharmacol 79:715-721
30. Faivre S, Kroemer G, Raymond E (2006) Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 5:671-688
31. Fan S, Meng Q, Saha T et al (2009) Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner. Cancer Res 69:6083-6091
32. Garikapaty VP, Ashok BT, Tadi K et al (2006) 3, 3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem Biophys Res Commun 340:718-725
33. Gartel AL, Serfas MS, Tyner AL (1996) p21 - negative regulator of the cell cycle. Proc Soc Exp Biol Med 213:138-149
34. Gong Y, Firestone GL, Bjeldanes LF (2006a) 3, 3'-diindolylmethane is a novel topoisomerase IIalpha catalytic inhibitor that induces S-phase retardation and mitotic delay in human hepatoma HepG2 cells. Mol Pharmacol 69:1320-1327
35. Gong Y, Sohn H, Xue L et al (2006b) 3, 3'-Diindolylmethane is a novel mitochondrial H (+)-ATP synthase inhibitor that can induce p21 (Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells. Cancer Res 66:4880-4887
36. Gudmundsdottir K, Ashworth A (2006) The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25:5864-5874
37. Hankinson O (1995) The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307-340
38. Heath EI, Heilbrun LK, Vaishampayan UN et al (2009) A phase-I dose escalation study of oral BR-DIM (BioResponse 3, 3'-Diindolylmethane) in castrate-resistant, non-metastatic, PSA relapse prostate cancer patients. ASCO Meeting Genitourinary Cancer Symposium, Chicago, IL
39. Hong C, Firestone GL, Bjeldanes LF (2002a) Bcl-2 family-mediated apoptotic effects of 3, 3'-diindolylmethane (DIM) in human breast cancer cells. Biochem Pharmacol 63:1085-1097
40. Hong C, Kim HA, Firestone GL et al (2002b) 3, 3'-Diindolylmethane (DIM) induces a G (1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21 (WAF1/CIP1) expression. Carcinogenesis 23:1297-1305
41. Huang X, Guo B (2006) Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells. Cancer Res 66:9245-9251
42. Ichite N, Chougule MB, Jackson T et al (2009) Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Clin Cancer Res 15:543-552
43. Iorio MV, Croce CM (2009) MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27:5848-5856
44. Iorio MV, Ferracin M, Liu CG et al (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070
45. Jacobs IC, Zeligs MA (1999) Facilitated absorption of a hydrophobic dietary ingredient. Proc Int Symp Control Rel Bioact Mater 26:958-959
46. Jacobs IC, Zeligs MA (2000) New formulation strategies for bioavailability enhancement of two poorly absorbed phytonutrient supplements: diindolylmethane and yohimbine bark extract. Proc Int Symp Control Rel Bioact Mater 27:1324-1325
47. Jellinck PH, Forkert PG, Riddick DS et al (1993) Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 45:1129-1136
48. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
49. Jin Y, Zou X, Feng X (2010) 3, 3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells. Anticancer Drugs 21:814-822
50. Juge N, Mithen RF, Traka M (2007) Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64:1105-1127
51. Kandala PK, Srivastava SK (2010) Activation of checkpoint kinase 2 by 3, 3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells. Mol Pharmacol 78:297-309
52. Kim EJ, Shin M, Park H et al (2009) Oral administration of 3, 3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. J Nutr 139:2373-2379
53. Kong D, Li Y, Wang Z et al (2007) Inhibition of angiogenesis and invasion by 3, 3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res 67:3310-3319
54. Kong D, Banerjee S, Huang W et al (2008) Mammalian target of rapamycin repression by 3, 3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells. Cancer Res 68:1927-1934
55. Lee SH, Kim JS, Yamaguchi K et al (2005) Indole-3-carbinol and 3, 3'-diindolylmethane induce expression of NAG-1 in a p53-independent manner. Biochem Biophys Res Commun 328:63-69
56. Li Y, Li X, Sarkar FH (2003) Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis. J Nutr 133:1011-1019
57. Li Y, Chinni SR, Sarkar FH (2005) Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells. Front Biosci 10:236-243
58. Li Y, Wang Z, Kong D et al (2007) Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3, 3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem 282:21542-21550
59. Li Y, Vanden Boom TG, Kong D et al (2009) Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69:6704-6712
60. Li Y, Li X, Guo B (2010) Chemopreventive agent 3, 3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases. Cancer Res 70:646-654
61. Maciejewska D, Rasztawicka M, Wolska I et al (2009) Novel 3, 3'-diindolylmethane derivatives: synthesis and cytotoxicity, structural characterization in solid state. Eur J Med Chem 44:4136-4147
62. McDougal A, Gupta MS, Morrow D et al (2001) Methyl-substituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats. Breast Cancer Res Treat 66:147-157
63. McGuire KP, Ngoubilly N, Neavyn M et al (2006) 3, 3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. J Surg Res 132:208-213
64. Morse MA, Stoner GD (1993) Cancer chemoprevention: principles and prospects. Carcinogenesis 14:1737-1746
65. Nachshon-Kedmi M, Yannai S, Haj A et al (2003) Indole-3-carbinol and 3, 3'-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 41:745-752
66. Nachshon-Kedmi M, Fares FA, Yannai S (2004a) Therapeutic activity of 3, 3'-diindolylmethane on prostate cancer in an in vivo model. Prostate 61:153-160
67. Nachshon-Kedmi M, Yannai S, Fares FA (2004b) Induction of apoptosis in human prostate cancer cell line, PC3, by 3, 3'-diindolylmethane through the mitochondrial pathway. Br J Cancer 91:1358-1363
68. Narayanan R, Yepuru M, Szafran AT et al (2010) Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancer. Cancer Res 70:842-851
69. Parkin DR, Malejka-Giganti D (2004) Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3, 3'-diindolylmethane and its parent compound indole-3-carbinol. Cancer Detect Prev 28:72-79
70. Rahimi M, Huang KL, Tang CK (2010) 3, 3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants. Cancer Lett 295:59-68
71. Rahman KW, Sarkar FH (2005) Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3, 3'-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res 65:364-371
72. Rahman KW, Li Y, Wang Z et al (2006) Gene expression profiling revealed survivin as a target of 3, 3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Cancer Res 66:4952-4960
73. Rahman KM, Ali S, Aboukameel A et al (2007) Inactivation of NF-kappaB by 3, 3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. Mol Cancer Ther 6:2757-2765
74. Rahman KM, Banerjee S, Ali S et al (2009) 3, 3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Cancer Res 69:4468-4475
75. Rajoria S, Suriano R, George A et al (2011) Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3, 3'-diindolylmethane in thyroid cancer. PLoS One 6:e15879
76. Reed GA, Arneson DW, Putnam WC et al (2006) Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3, 3'-diindolylmethane. Cancer Epidemiol Biomarkers Prev 15:2477-2481
77. Reed GA, Sunega JM, Sullivan DK et al (2008) Single-dose pharmacokinetics and tolerability of absorption-enhanced 3, 3'-diindolylmethane in healthy subjects. Cancer Epidemiol Biomarkers Prev 17:2619-2624
78. Riby JE, Firestone GL, Bjeldanes LF (2008) 3, 3'-diindolylmethane reduces levels of HIF-1alpha and HIF-1 activity in hypoxic cultured human cancer cells. Biochem Pharmacol 75:1858-1867
79. Roy A, Ganguly A, Bose Dasgupta S et al (2008) Mitochondria-dependent reactive oxygen speciesmediated programmed cell death induced by 3, 3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. Mol Pharmacol 74:1292-1307
80. Savino JA, III, Evans JF, Rabinowitz D et al (2006) Multiple, disparate roles for calcium signaling in apoptosis of human prostate and cervical cancer cells exposed to diindolylmethane. Mol Cancer Ther 5:556-563
81. Sepkovic DW, Bradlow HL, Bell M (2001) Quantitative determination of 3, 3'-diindolylmethanein urine of individuals receiving indole-3-carbinol. Nutr Cancer 41:57-63
82. Sepkovic DW, Stein J, Carlisle AD et al (2009) Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model. Cancer Epidemiol Biomarkers Prev 18:2957-2964
83. Sepkovic DW, Stein J, Carlisle AD et al (2011) Results from a dose response study using 3, 3'-diindolylmethane in the K14-HPV16 transgenic mouse model: Cervical histology. Cancer Prev Res (Phila) 4:890-896
84. Stresser DM, Bjeldanes LF, Bailey GS et al (1995) The anticarcinogen 3, 3'-diindolylmethane is an inhibitor of cytochrome P-450. J Biochem Toxicol 10:191-201
85. Sun S, Han J, Ralph WM, Jr et al (2004) Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro. Cell Stress Chaperones 9:76-87
86. Tadi K, Chang Y, Ashok BT et al (2005) 3, 3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease. Biochem Biophys Res Commun 337:1019-1025
87. Thimmulappa RK, Mai KH, Srisuma S et al (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62:5196-5203
88. Vivar OI, Saunier EF, Leitman DC et al (2010) Selective Activation of Estrogen Receptor-{beta} Target Genes by 3, 3'-Diindolylmethane. Endocrinology 151:1662-1667
89. Wang Z, Yu BW, Rahman KM et al (2008) Induction of growth arrest and apoptosis in human breast cancer cells by 3, 3-diindolylmethane is associated with induction and nuclear localization of p27kip. Mol Cancer Ther 7:341-349
90. Wattenberg LW (1985) Chemoprevention of cancer. Cancer Res 45:1-8
91. Wortelboer HM, De Kruif CA, Van Iersel AA et al (1992) Acid reaction products of indole-3-carbinol and their effects on cytochrome P450 and phase II enzymes in rat and monkey hepatocytes. Biochem Pharmacol 43:1439-1447
92. Xue L, Firestone GL, Bjeldanes LF (2005) DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene 24:2343-2353
93. Zhang S, Shen HM, Ong CN (2005) Down-regulation of c-FLIP contributes to the sensitization effect of 3, 3'-diindolylmethane on TRAIL-induced apoptosis in cancer cells. Mol Cancer Ther 4:1972-1981
94. Zhang B, Pan X, Cobb GP et al (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302:1-12